About Abiraterone Abiratas 500mg
Abiratas 500mg from Intas Pharmaceuticals Ltd. is a brilliant and towering option in the hormonal therapy sphere for metastatic castration-resistant prostate cancer (mCRPC). Each HDPE bottle contains 60 high-potency, film-coated tablets, formulated with Abiraterone Acetate 500 mg. Abiratas 500mg has garnered favorable reviews for its valorous ability to inhibit disease progression. Available at a promotion with the lowest price in the export market, its oral route ensures ease of use. Only prescribed by oncologists, this prescription-only medicine underscores a commitment to patient safety.
Core Features and Application
Abiratas 500mg showcases a high-potency anti-androgen effect, specifically formulated for use in adult men diagnosed with mCRPC. Its robust action is heightened by oral administration, making it accessible for at-home therapy. The tablets are white to off-white, oval-shaped, and film-coated, ensuring stability and ease of swallowing. This medicine is strictly for prescription use and is ideal for patients under oncological supervision, maximizing safety through careful monitoring and tailored therapies.
Certifications and Supply Details
Abiratas 500mg adheres to rigorous quality certifications, cementing its reputation in the export market. Exchange rates and supply ability are optimized for large-scale availability, meeting the demands of global distributors and traders. Packaged in durable HDPE bottles, it comes with a shelf life of 24 months, ensuring long-term storage and viability. Packaging details ensure product protection against moisture and light, safeguarding its efficacy throughout its logistics journey.
FAQs of Abiraterone Abiratas 500mg:
Q: How should Abiratas 500mg be used for the treatment of prostate cancer?
A: Abiratas 500mg should be taken orally as prescribed by your oncologist, typically in the treatment of metastatic castration-resistant prostate cancer. Follow the prescribed dosage and consult your physician regarding timing and administration.
Q: What is the primary benefit of using Abiratas 500mg in prostate cancer therapy?
A: Abiratas 500mg offers a high-potency anti-androgen effect, helping to inhibit disease progression in patients with mCRPC, leading to improved therapeutic outcomes when supervised by an oncologist.
Q: When should liver function and other precautions be monitored during Abiratas 500mg therapy?
A: Liver function should be monitored regularly before and during treatment with Abiratas 500mg, as recommended by your oncologist, especially if you have underlying hypertension or cardiac conditions.
Q: Where can Abiratas 500mg be purchased and who is eligible to use it?
A: Abiratas 500mg is available through licensed distributors, suppliers, and pharmacies in India. It should only be purchased and used under the strict supervision of an oncologist and is not suitable for women or individuals with hypersensitivity to its ingredients.
Q: What are the storage instructions for Abiratas 500mg tablets to maintain their efficacy?
A: Store Abiratas 500mg tablets below 30C, in a dry place protected from moisture and light, and ensure the bottle remains tightly closed to preserve stability and potency throughout its shelf life.